We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$175M
2
WELL icon
Welltower
WELL
+$148M
3
CUZ icon
Cousins Properties
CUZ
+$121M
4
DLR icon
Digital Realty Trust
DLR
+$103M
5
VICI icon
VICI Properties
VICI
+$96.6M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
1176
Precigen
PGEN
$1.97B
$4K ﹤0.01%
708
+307
+77% +$1.77K
RNAM
1177
DELISTED
Avidity Biosciences
RNAM
$4K ﹤0.01%
156
+85
+120% +$1.85K
SGMO
1178
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
498
+232
+87% +$2.29K
SRRK icon
1179
Scholar Rock
SRRK
$5.92B
$4K ﹤0.01%
118
+55
+87% +$1.93K
YMAB
1180
DELISTED
Y-mAbs Therapeutics
YMAB
$4K ﹤0.01%
149
+73
+96% +$2.3K
IMGN
1181
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
693
+309
+80% +$1.78K
CCXI
1182
DELISTED
ChemoCentryx, Inc.
CCXI
$4K ﹤0.01%
239
+102
+74% +$1.59K
FMTX
1183
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$4K ﹤0.01%
162
+73
+82% +$1.73K
AFMD
1184
DELISTED
Affimed
AFMD
$3K ﹤0.01%
41
+22
+116% +$1.45K
AKRO
1185
DELISTED
Akero Therapeutics
AKRO
$3K ﹤0.01%
119
+54
+83% +$1.22K
AMPH icon
1186
Amphastar Pharmaceuticals
AMPH
$888M
$3K ﹤0.01%
165
+76
+85% +$1.49K
CRNX icon
1187
Crinetics Pharmaceuticals
CRNX
$8.88B
$3K ﹤0.01%
132
+70
+113% +$1.46K
KYNB
1188
Kyntra Bio
KYNB
$28.2M
$3K ﹤0.01%
13
+6
+86% +$2.13K
GOSS icon
1189
Gossamer Bio
GOSS
$100M
$3K ﹤0.01%
260
+117
+82% +$1.08K
IDYA icon
1190
IDEAYA Biosciences
IDYA
$3.48B
$3K ﹤0.01%
132
+77
+140% +$1.8K
IMVT icon
1191
Immunovant
IMVT
$7.99B
$3K ﹤0.01%
394
+210
+114% +$1.89K
INVA icon
1192
Innoviva
INVA
$1.61B
$3K ﹤0.01%
191
– –
ITOS
1193
DELISTED
iTeos Therapeutics
ITOS
$3K ﹤0.01%
121
+55
+83% +$1.44K
KROS icon
1194
Keros Therapeutics
KROS
$199M
$3K ﹤0.01%
80
+36
+82% +$1.28K
NKTX icon
1195
Nkarta
NKTX
$159M
$3K ﹤0.01%
113
+52
+85% +$1.65K
OCUL icon
1196
Ocular Therapeutix
OCUL
$1.85B
$3K ﹤0.01%
262
+128
+96% +$1.44K
OMER icon
1197
Omeros
OMER
$816M
$3K ﹤0.01%
214
+98
+84% +$1.47K
ONON icon
1198
On Holding
ONON
$12.6B
$3K ﹤0.01%
+113
New +$3.97K
ORIC icon
1199
Oric Pharmaceuticals
ORIC
$1.23B
$3K ﹤0.01%
135
+66
+96% +$1.34K
PECO icon
1200
Phillips Edison & Co
PECO
$5.37B
$3K ﹤0.01%
+96
New +$2.82K
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.